ITGB1 and non-small cell lung carcinoma: Previous studies have shown that the activation of ITGB1/FAK pathway signal can promote EMT and angiogenesis in lung cancer, liver cancer and non-small cell lung cancer (Guo et al., 2020; Wang and Chang, 2020; Li et al., 2021).